Monitoring of the human serum albumin carbonylation level through determination of guanidino group content

Analytical Biochemistry

Volumn 433, Issue 2, 2013, Pages 162-167

  Aćimović, Jelena M ^a   Jovanović, Vesna B ^a   Srećković, Vesna Dimitrijević ^b   Penezić Romanjuk, Ana Z ^a   Mandić, Ljuba M ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Carbonylation of HSA guanidine group; Diabetes; Methylglyoxal; Spectrophotometric determination

Indexed keywords

AFFINITY CHROMATOGRAPHY; CARBONYLATION; MEDICAL PROBLEMS; PROTEINS; SPECTROPHOTOMETERS; SPECTROPHOTOMETRY;

ACCURACY AND PRECISION; METHYLGLYOXAL; PROTEIN CARBONYLATION; RELATIVE STANDARD DEVIATIONS; SPECTRO-PHOTOMETRIC METHOD; SPECTROPHOTOMETRIC DETERMINATION; STANDARD ADDITION METHOD; VASCULAR COMPLICATIONS;

SODIUM COMPOUNDS;

ARGININE; GUANIDINE DERIVATIVE; HUMAN SERUM ALBUMIN; METHYLGLYOXAL;

AFFINITY CHROMATOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; IN VITRO STUDY; MEASUREMENT ACCURACY; MONITORING; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN CARBONYLATION;

EID: 84870690241     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2012.10.028     Document Type: Article

References (33)

1. K.M. Desai, T. Chang, H. Wang, A. Banigesh, A. Dhar, J. Liu, A. Untereiner, and L. Wu Oxidative stress and aging: is methylglyoxal the hidden enemy? Can. J. Physiol. Pharmacol. 88 2010 273 284
2. α- acetyllysine, and bovine serum albumin J. Biol. Chem. 269 1994 32299 322305
3. H. Odani, T. Shinzato, Y. Matsumoto, J. Usami, and K. Maeda Increase in three α, β-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction Biochem. Biophys. Res. Commun. 256 1999 89 93
4. J. Lu, E. Randell, Y.C. Han, K. Adeli, J. Krahn, and Q.H. Meng Inreased plasma methylglyoxal level, inflammation, and vascular endothelial dysfunction in diabetic nephropathy Clin. Biochem. 44 2011 307 311
5. K. Mera, K. Takeo, M. Izumi, T. Maruyama, R. Nagai, and M. Otagiri Effect of reactive-aldehydes on the modification and dysfunction of human serum albumin J. Pharm. Sci. 99 2010 1614 1625
6. P. Faure, L. Troncy, M. Lecomte, N. Wiernsperger, M. Lagarde, D. Ruggiero, and S. Halimi Albumin antioxidant capacity is modified by methylglyoxal Diabetes Metab. 31 2005 169 177
7. M.T. Schram, C.G. Schalkwijk, A.H. Bootsma, J.H. Fuller, N. Chaturvedi, and C.D. Stehouwer Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB prospective complications study Hypertension 46 2005 232 237
8. Diabetic Control and Complication Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N. Engl. J. Med. 329 1993 977 986
9. J.W. Baynes, and S.R. Thorpe Glycoxidation and lipoxidation in atherogenesis Free Radic. Biol. Med. 28 2000 1708 1716
10. P. Chellan, and R.H. Nagaraj Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes Arch. Biochem. Biophys. 368 1999 98 104
11. A. Lapolla, P. Traldi, and D. Fedele Importance of measuring products of non-enzymatic glycation of proteins Clin. Biochem. 38 2005 103 115
12. M.A. Karsdal, K. Henriksen, D.J. Leeming, T. Woodworth, E. Vassiliadis, and A.C. Bay-Jensen Novel combinations of post-translational modification (PTM) neo-epitopes provide tissue-specific biochemical markers: are they the cause or the consequence of the disease? Clin. Biochem. 43 2010 793 804
13. J. Zeng, and M.J. Davies Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of α-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins Chem. Res. Toxicol. 18 2005 1232 1241
14. A.A. Mostafa, E.W. Randell, S.C. Vasdev, V.D. Gill, Y. Han, V. Gadag, A.A. Raouf, and H. El Said Plasma protein advanced glycation end products, carboxymethyl cysteine and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes Mol. Cell. Biochem. 302 2007 35 42
15. T.P. Degenhardt, S.R. Thorpe, and J.W. Baynes Chemical modification of proteins by methylglyoxal Cell Mol. Biol. 44 1998 1139 1145
16. R. Singh, A. Barden, T. Mori, and L. Beilin Advanced glycation end-products: a review Diabetologia 44 2001 129 146
17. M.E. Westwood, and P.J. Thornalley Molecular characteristics of methylglyoxal-modified bovine and human serum albumins: comparison with glucose-derived advanced glycation endproduct-modified serum albumins J. Protein Chem. 14 1995 359 372
18. J.M. Acimovic, V.B. Jovanovic, M.R. Veselinovic, V.D. Sreckovic, and L.M. Mandic Method for monitoring of the protein amino group changes during carbonylation Clin. Biochem. 44 2011 994 999
19. C.S.P. Sastry, and M.K. Tummuru Spectrophotometric determination of arginine in proteins Food Chem. 15 1984 257 260
20. J.P. Dupin, F. Casadebaig, J.P. Pometan, M. Petraud, B. Barbe, and J. Moulines The Sakaguchi reaction: III. Structural study by nuclear magnetic resonance of colored compounds Ann. Pharm. Fr. 37 1979 523 530 (in French)
21. R.J. Slater Experiments in Molecular Biology 1986 Humana Press Totowa, NJ p. 269
22. Hoeffer Scientific Instruments Electrophoresis Instruments and Accessories: Techniques and Exercises 1991 Hoeffer Scientific Instruments San Francisco
23. 1c by an immunoturbidimetric assay compared to a standard HPLC method Am. J. Clin. Pathol. 104 1995 89 95
24. J. Himmelfarb, and E. McMonagle Albumin is the major plasma protein target of oxidant stress in uremia Kidney Int. 60 2001 358 363
25. Y. Han, E. Randell, S. Vasdev, V. Gill, M. Curran, L.A. Newhook, M. Grant, D. Hagerty, and C. Schneider Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone is elevated in young, complication-free patients with type 1 diabetes Clin. Biochem. 42 2009 562 569
26. A. Phillips, A.G. Shaper, and P.H. Whincup Association between serum albumin and mortality from cardiovascular diseases, cancer, and other causes Lancet 2 1989 1434 1436
27. M.P. Cohen, R.S. Clements, J.A. Cohen, and C.W. Shearman Glycated albumin promotes a generalized vasculopathy in the db/db mouse Biochem. Biophys. Res. Commun. 218 1996 72 75
28. M.T. Schram, C.G. Schalkwijk, and A.H. Bootsma Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB prospective complications study Hypertension 46 2005 232 237
29. C.G. Schalkwijk, N. Ligtvoet, H. Twaalfhoven, A. Jager, H.G. Blaauwgeers, R.O. Schlingemann, L. Tarnow, H.H. Parving, C.D. Stehouwer, and V.W. van Hinsbergh Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries Diabetes 48 1999 2446 2453
30. Y. Hattori, M. Suzuki, S. Hattori, and K. Kasai Vascular smooth muscle cell activation by glycated albumin (Amadori adducts) Hypertension 39 2002 22 28
31. 1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control Endocr. J. 54 2007 139 144
32. M. Koga, and S. Kasayama Clinical impact of glycated albumin as another glycemic control marker Endocr. J. 57 2010 751 762
33. T. Kouzuma, T. Usami, M. Yamakoshi, M. Takahashi, and S. Imamura An enzymatic method for the measurement of glycated albumin in biological samples Clin. Chim. Acta 324 2002 61 71